Form 4: Genelux Corp Executive Sells Shares to Cover Taxes

Joseph Cappello, VP of Pharmaceutical Development at Genelux Corp, sold 4,737 shares of common stock to cover estimated taxes related to vesting restricted stock units.

Summary

• On May 12, 2025, Joseph Cappello, VP of Pharmaceutical Development at Genelux Corp, sold 4,737 shares of common stock.
• The shares were sold at a price of $2.92 per share.
• The sale was executed to cover estimated taxes associated with the vesting of restricted stock units.
• Following the transaction, Cappello directly owns 52,266 shares of Genelux Corp.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale of shares to cover taxes is a neutral event and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.

Stakeholder Impact

• The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale.

Key Dates

Keywords

Genelux Corp, Joseph Cappello, Form 4, Share Sale, Restricted Stock Units, GNLX, Beneficial Ownership